# OnCo record nct07218003 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07218003/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07218003", "NCT07218003" ;
  schema:name "RNDO-564 alone or with pembrolizumab"@en ;
  schema:alternateName "A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4"@en ;
  schema:description "This early study tests RNDO-564 alone or with pembrolizumab in selected advanced tumors. It examines dose, side effects and early treatment activity."@en ;
  schema:url <https://onco.cc/trials/nct07218003/> ;
  schema:dateModified "2026-10-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07218003>, <https://clinicaltrials.ucsf.edu/trial/NCT07218003> ;
  onco:status "recruiting" ;
  onco:tag "ucsf-breast-coverage", "interventional" ;
  onco:phase "1" ;
  schema:startDate "2025-11-17" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/tnbc/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/> ;
  onco:institutions <https://onco.cc/institutions/ucsf/> .